Federated Hermes’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $614K | Buy |
+12,617
| New | +$614K | ﹤0.01% | 1285 |
|
|
2024
Q4 | – | Sell |
-447,606
| Closed | -$21M | – | 2098 |
|
|
2024
Q3 | $21M | Hold |
447,606
| – | – | 0.05% | 409 |
|
|
2024
Q2 | $24.2M | Hold |
447,606
| – | – | 0.06% | 363 |
|
|
2024
Q1 | $30.5M | Sell |
447,606
-60,494
| -12% | -$4.12M | 0.07% | 328 |
|
|
2023
Q4 | $31.8M | Hold |
508,100
| – | – | 0.08% | 282 |
|
|
2023
Q3 | $23.1M | Sell |
508,100
-658
| -0.1% | -$29.9K | 0.06% | 331 |
|
|
2023
Q2 | $28.6M | Hold |
508,758
| – | – | 0.07% | 309 |
|
|
2023
Q1 | $23M | Hold |
508,758
| – | – | 0.06% | 352 |
|
|
2022
Q4 | $20.7M | Hold |
508,758
| – | – | 0.06% | 375 |
|
|
2022
Q3 | $33.2M | Sell |
508,758
-72,160
| -12% | -$4.72M | 0.1% | 262 |
|
|
2022
Q2 | $35.3M | Hold |
580,918
| – | – | 0.1% | 260 |
|
|
2022
Q1 | $36.5M | Hold |
580,918
| – | – | 0.08% | 293 |
|
|
2021
Q4 | $44M | Hold |
580,918
| – | – | 0.08% | 298 |
|
|
2021
Q3 | $65M | Hold |
580,918
| – | – | 0.12% | 229 |
|
|
2021
Q2 | $94M | Sell |
580,918
-5,900
| -1% | -$955K | 0.18% | 160 |
|
|
2021
Q1 | $71.5M | Sell |
586,818
-50,282
| -8% | -$6.13M | 0.14% | 195 |
|
|
2020
Q4 | $97.5M | Sell |
637,100
-131,150
| -17% | -$20.1M | 0.2% | 129 |
|
|
2020
Q3 | $64.3M | Sell |
768,250
-309,750
| -29% | -$25.9M | 0.15% | 159 |
|
|
2020
Q2 | $79.2M | Hold |
1,078,000
| – | – | 0.2% | 124 |
|
|
2020
Q1 | $45.7M | Sell |
1,078,000
-183,700
| -15% | -$7.79M | 0.13% | 170 |
|
|
2019
Q4 | $76.8M | Buy |
1,261,700
+400,037
| +46% | +$24.4M | 0.17% | 142 |
|
|
2019
Q3 | $35.3M | Buy |
861,663
+30,000
| +4% | +$1.23M | 0.09% | 240 |
|
|
2019
Q2 | $39.2M | Buy |
831,663
+67,400
| +9% | +$3.17M | 0.1% | 231 |
|
|
2019
Q1 | $27.3M | Hold |
764,263
| – | – | 0.07% | 278 |
|
|
2018
Q4 | $21.8M | Hold |
764,263
| – | – | 0.06% | 302 |
|
|
2018
Q3 | $33.9M | Buy |
764,263
+132,863
| +21% | +$5.89M | 0.08% | 253 |
|
|
2018
Q2 | $37.1M | Buy |
+631,400
| New | +$37.1M | 0.11% | 161 |
|